Ketamine for treatment‐resistant bipolar depression—need for more data!
Authors:
- 22 September 2021
- journal article
- editorial
- Published by Wiley in Bipolar Disorders
- Vol. 23 (7) , 728-729
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Hypomania associated with high dose ketamine treatmentBipolar Disorders, 2021
- A Systematic Review on the Efficacy of Intravenous Racemic Ketamine for Bipolar DepressionJournal of Clinical Psychopharmacology, 2021
- A preliminary study of adjunctive ketamine for treatment-resistant bipolar depressionJournal of Affective Disorders, 2020
- Insulin-stimulated mTOR activation in peripheral blood mononuclear cells associated with early treatment response to lithium augmentation in rodent model of antidepressant-resistanceTranslational Psychiatry, 2019
- Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorderBipolar Disorders, 2018